Hancock Jaffe Laboratories, Inc. Gains 63.89%
Fri, Aug 21, 2020 at 05:34 PM
Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) jumped higher at $0.46, representing a gain of 63.9%. On Thu 20 Aug 20, HJLI:NASDAQ hit a New 2-Week Low of $0.28. The stock appeared on our News Catalysts scanner on Fri 21 Aug 20 at 09:09 AM in the 'BIOTECH' category. From Thu 06 Aug 20, the stock recorded 20.00% Up Days and 9.09% Green Days
The stock spiked on Mon 10 Aug 20 at $0.46 with a volume of 11M+.
About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)
Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.
Top 10 Gainers:
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 63.89%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 30.96%
- Harpoon Therapeutics, Inc. (HARP:NASDAQ), 30.63%
- ShiftPixy, Inc. (PIXY:NASDAQ), 27.03%
- Velocity Financial, Inc. (VEL:NYSE), 24.88%
- Gridsum Holding Inc. (GSUM:NASDAQ), 24.17%
- Moxian, Inc. (MOXC:NASDAQ), 22%
- Midatech Pharma plc (MTP:NASDAQ), 21.9%
- SPAR Group, Inc. (SGRP:NASDAQ), 19.91%
- The Buckle, Inc. (BKE:NYSE), 18.81%